Explaining Rising Heart Failure Mortality in Medicare

解释医疗保险中不断上升的心力衰竭死亡率

基本信息

项目摘要

! ! PROJECT(SUMMARY/ABSTRACT( The clinical and financial burden of heart failure (HF) among older adults in the United States is high, with over 400,000 hospitalizations and $30 billion in spending annually. After a decade of steady improvement in short- term mortality among older adults hospitalized with HF, mortality within 30 days of hospital discharge is now increasing in this population. Little is known, however, about the factors driving this concerning trend. This study proposes to use administrative and qualitative data to evaluate patient, hospital, and policy level factors that explain rising mortality. In Aim 1, we will use Medicare data to determine if increasing clinical and/or social risk among older adults hospitalized with HF, or worsening hospital care quality, explain recent trends in mortality. In Aim 2, we will examine whether the Hospital Readmissions Reduction Program (HRRP) - a federal policy that intended to improve HF care by financially penalizing hospitals with high 30-day readmission rates – has incentivized inappropriate post-discharge care strategies (i.e. avoiding indicated readmissions) that have been associated with increased mortality. Our preliminary data suggest that the rise in mortality is being driven by patients with HF who are not readmitted to the hospital, providing initial support for this hypothesis. In Aim 3, we will use semi-structured physician interviews to understand if their decision-making regarding the care of HF patients has changed since HRRP. In addition, we will interview patients with HF to explore their awareness and perception of this policy. These interviews will also be used to gather preliminary data on potential strategies to improve post-discharge HF care. The overarching goal of this proposal is to understand why short-term mortality among older adults with HF is rising in the United States, which may have significant clinical and policy implications. The first two aims of this analysis will inform whether more resources should be allocated to sites that care for clinically high-risk or socially disadvantaged populations and if current federal policies (HRRP) should be redesigned or eliminated. The third aim will lay the foundation for future research to develop and test novel strategies, based on physician and patient preferences, to improve post-discharge HF care. This research will be accomplished in the setting of a comprehensive career development program designed to provide Dr. Wadhera, an early career investigator and cardiologist, with the skills needed to become an independent investigator in cardiovascular medicine and health policy. His long-term career goal is to use large datasets at the population level, and qualitative methods at the individual level, to comprehensively evaluate the impact of health policies on cardiovascular care and outcomes. An outstanding mentoring team and advisory committee of established clinical investigators in the fields of cardiovascular medicine, outcomes research, health policy, and advanced biostatistical and qualitative methods will guide Dr. Wadhera in his transition to independence over the course of the award period. !
! ! 项目(摘要/摘要( 美国老年人心力衰竭 (HF) 的临床和经济负担很高,超过 每年有 40 万人次住院治疗和 300 亿美元的支出。经过十年的稳步改进 因心力衰竭住院的老年人的足月死亡率,出院 30 天内的死亡率现为 这个人口数量不断增加。然而,人们对推动这一令人担忧的趋势的因素知之甚少。这 研究建议使用行政和定性数据来评估患者、医院和政策层面的因素 这解释了死亡率上升的原因。在目标 1 中,我们将使用医疗保险数据来确定是否增加临床和/或社会 因心力衰竭住院的老年人的风险或医院护理质量恶化,解释了最近的趋势 死亡。在目标 2 中,我们将研究医院再入院减少计划 (HRRP) 是否是联邦 旨在通过对 30 天再入院率高的医院进行经济处罚来改善心力衰竭护理的政策 – 激励了不适当的出院后护理策略(即避免指定的再入院), 与死亡率增加有关。我们的初步数据表明,死亡率上升是由 未再次入院的心力衰竭患者,为这一假设提供了初步支持。瞄准 3、我们将使用半结构化的医生访谈来了解他们是否做出了有关护理的决策 自 HRRP 以来,心力衰竭患者发生了变化。此外,我们还将采访心力衰竭患者,以探讨他们的情况 对本政策的认识和看法。这些访谈还将用于收集初步数据 改善出院后心力衰竭护理的潜在策略。该提案的总体目标是了解 为什么美国老年人心力衰竭的短期死亡率不断上升,这可能对 临床和政策影响。该分析的前两个目标将告知是否应该投入更多资源 分配给照顾临床高风险或社会弱势群体的场所,并且如果当前联邦 政策(HRRP)应该重新设计或取消。第三个目标将为未来的研究奠定基础 根据医生和患者的喜好制定和测试新策略,以改善出院后心力衰竭 关心。这项研究将在制定全面的职业发展计划的情况下完成 旨在为早期职业调查员和心脏病专家 Wadhera 博士提供以下技能: 成为心血管医学和卫生政策的独立研究者。他的长期职业目标是 在人口层面使用大型数据集,在个体层面使用定性方法, 全面评估卫生政策对心血管护理和结果的影响。一个杰出的 由心血管领域现有临床研究人员组成的指导团队和咨询委员会 医学、结果研究、卫生政策以及先进的生物统计和定性方法将指导博士。 瓦德拉在获奖期间向独立过渡。 !

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rishi Kumar Wadhera其他文献

Rishi Kumar Wadhera的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rishi Kumar Wadhera', 18)}}的其他基金

Cardiovascular Health of Low-Income Working-Age Adults in the US: Health Care Access, Policy, and the Pandemic
美国低收入工作年龄成年人的心血管健康:医疗保健获取、政策和大流行
  • 批准号:
    10502097
  • 财政年份:
    2022
  • 资助金额:
    $ 17.25万
  • 项目类别:
Cardiovascular Health of Low-Income Working-Age Adults in the US: Health Care Access, Policy, and the Pandemic
美国低收入工作年龄成年人的心血管健康:医疗保健获取、政策和大流行
  • 批准号:
    10641953
  • 财政年份:
    2022
  • 资助金额:
    $ 17.25万
  • 项目类别:
Explaining Rising Heart Failure Mortality in Medicare
解释医疗保险中不断上升的心力衰竭死亡率
  • 批准号:
    9977244
  • 财政年份:
    2019
  • 资助金额:
    $ 17.25万
  • 项目类别:
Explaining Rising Heart Failure Mortality in Medicare
解释医疗保险中不断上升的心力衰竭死亡率
  • 批准号:
    10210325
  • 财政年份:
    2019
  • 资助金额:
    $ 17.25万
  • 项目类别:
Explaining Rising Heart Failure Mortality in Medicare
解释医疗保险中不断上升的心力衰竭死亡率
  • 批准号:
    10437732
  • 财政年份:
    2019
  • 资助金额:
    $ 17.25万
  • 项目类别:
Explaining Rising Heart Failure Mortality in Medicare
解释医疗保险中不断上升的心力衰竭死亡率
  • 批准号:
    10641030
  • 财政年份:
    2019
  • 资助金额:
    $ 17.25万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.25万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 17.25万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.25万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.25万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.25万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.25万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.25万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 17.25万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 17.25万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 17.25万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了